RetinEye AId
RetinEye AId detects the presence and stages of Diabetic Retinopathy (DR), especially the early stages, which are difficult to diagnose. By using AI and advanced image processing algorithms, it provides a fast, accurate, and explainable diagnostic solution, helping prevent the disease from progressing to blindness. RetinEye AId minimizes malpractice, reduces examination times, and improves early detection, supporting doctors in their decision-making processes.
Why AId Core Solutions?
Reliable Diagnosis with Innovative Technology
RetinAId uses advanced AI to accurately detect early retinal diseases, reducing errors and enhancing decision-making.
Patient-Centered Approach
Our AI-driven solution simplifies treatment, detects risks early, and prevents blindness-causing complications.
Easy Integration
RetinAI integrates with retinal imaging devices and hospital systems, allowing quick setup without system changes.
Advanced Technology with User-Friendly Interface
RetinAI combines advanced technology with a user-friendly interface, enabling doctors to quickly access analysis results and focus more on patients care.
Verified Expertise and Trust
Our expert team in health and technology has extensive experience in AI-powered diagnostic systems, and our product is supported by health authorities both in Turkey and globally.
Commitment to Social Benefit
Our goal is to reduce blindness, ease healthcare burdens, and build a healthier future together through improved eye care.
Who is AId Core Solutions for?
What is Diabetic Retinopathy?
Diabetic Retinopathy (DR) is one of the most serious complications threatening the eye health of diabetic patients. It occurs as a result of long-term damage to the retinal blood vessels caused by diabetes and can lead to vision loss if not diagnosed early.
Diabetic Retinopathy179M
Diabetic Retinopathy (DR) is a serious complication of diabetes, with over 642 million people projected to be affected by 2040. RetinEye AId provides early detection, helping reduce vision loss and easing healthcare burdens.
AMD196M
Age-Related Macular Degeneration (AMD) is a retinal disease commonly seen in individuals over the age of 50, which impairs detailed vision due to the damage it causes in the macula. AMD has two forms: 'dry' and 'wet.' Early diagnosis is crucial for the success of treatment in Age-Related Macular Degeneration.
Drusen145M
Drusen are small yellow deposits on the retina, often associated with age-related macular degeneration (AMD). While they don't always cause vision loss, their presence can increase the risk of developing more severe AMD. Early detection is key for effective monitoring and prevention.
Glaucoma80M
Glaucoma is a group of eye diseases that damage the optic nerve, often due to high intraocular pressure. It is a leading cause of blindness, particularly in older adults. Early detection and treatment are crucial to prevent vision loss.
Macular edema27M
Macular edema is the swelling of the macula, the central part of the retina, often caused by conditions like diabetic retinopathy or retinal vein occlusion. It can lead to blurred or distorted central vision. Early diagnosis and treatment are important to preserve vision.
Hypertensive retinopathy225M
Hypertensive retinopathy is damage to the retina caused by high blood pressure. It can lead to changes in the blood vessels of the retina, potentially causing vision problems. Early detection and control of blood pressure are essential to prevent further damage.